Product Name | MF | CAS | Details |
---|
Vandetanib | C22H24BrFN4O2 | 443913-73-3 | Details |
Canertinib | C24H25ClFN5O3 | 267243-28-7 | Details |
1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)- | C26H30FN7O3 | 722544-51-6 | Details |
Motesanib | C22H23N5O | 453562-69-1 | Details |
NVP-BEZ 235 | C30H23N5O | 915019-65-7 | Details |
NVP-TAE684 | C30H40ClN7O3S | 761439-42-3 | Details |
4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE, 7-METHYL-2-(4-MORPHOLINYL)-9-[1-(PHENYLAMINO)ETHYL]- | C21H24N4O2 | 663619-89-4 | Details |
CYC-116 | C18H20N6OS | 693228-63-6 | Details |
Olaparib | C24H23FN4O3 | 763113-22-0 | Details |
VX 702 | C19H12F4N4O2 | 745833-23-2 | Details |
Ruxolitinib | C17H18N6 | 941678-49-5 | Details |
PD0332991 Isethionate | C26H35N7O6S | 827022-33-3 | Details |
XL 228 | C22H31N9O | 898280-07-4 | Details |
GNE 7915 | C19H21F4N5O3 | 1351761-44-8 | Details |
Tofacitinib | C16H20N6O | 477600-75-2 | Details |
4-iodo-3-nitrobenzamide | C7H5IN2O3 | 160003-66-7 | Details |
Docetaxel | C43H53NO14 | 114977-28-5 | Details |
17-AAG | C31H43N3O8 | 75747-14-7 | Details |
LY 294002 HYDROCHLORIDE | C19H17NO3 | 154447-36-6 | Details |
Afatinib (BIBW 2992) | C24H25ClFN5O3 | 439081-18-2 | Details |
AMG-706 | C22H29N5O9P2 | 857876-30-3 | Details |
Crizotinib | C21H22Cl2FN5O | 877399-52-5 | Details |
CUDC-101 | C24H26N4O4 | 1012054-59-9 | Details |
BI-6727 | C34H50N8O3 | 755038-65-4 | Details |
AP24534(Ponatinib) | C29H27F3N6O | 943319-70-8 | Details |
Carfilzomib | C40H57N5O7 | 868540-17-4 | Details |
PF-00299804 | C24H27ClFN5O3 | 1042385-75-0 | Details |
Birinapant | C42H56F2N8O6 | 1260251-31-7 | Details |
Deltarasin (hydrochloride) | C40H40Cl3N5O | 1440898-82-7 | Details |
AZ-5104 | C27H31N7O2 | 1421373-98-9 | Details |
Raltegravir potassium | C20H20FN6O5.K | 871038-72-1 | Details |
Vatalanib base | C20H15ClN4 | 212141-54-3 | Details |
ABT 263 | C47H55ClF3N5O6S3 | 923564-51-6 | Details |
Luminespib | C26H31N3O5 | 747412-49-3 | Details |
N-(Cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]benzamide | C23H22N6O2 | 1056634-68-4 | Details |
indoleaMine-2,3-dioxygenase inhibitor INCB024360 | C9H7ClFN5O2 | 914471-09-3 | Details |
Erlotinib hydrochloride | C22H24ClN3O4 | 183319-69-9 | Details |
Entinostat | C21H20N4O3 | 209783-80-2 | Details |
Lapatinib ditosylate | C41H40ClFN4O11S3 | 388082-78-8 | Details |
VARESPLADIB | C21H20N2O5 | 172732-68-2 | Details |
Tandutinib | C31H42N6O4 | 387867-13-2 | Details |
BI 2536 | C28H39N7O3 | 755038-02-9 | Details |
A 769662 | C20H12N2O3S | 844499-71-4 | Details |
HYPOTHEMYCIN | C19H22O8 | 76958-67-3 | Details |
(S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one | C23H30N8O3S | 1032754-93-0 | Details |
N-Hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide hydrochloride | C20H22ClN3O2 | 1310693-92-5 | Details |
PF-3758309 | C25H30N8OS | 898044-15-0 | Details |
ALK/IGF1R inhibitor | C24H25ClN6O | 1356962-20-3 | Details |
Paclitaxel | C47H51NO14 | 33069-62-4 | Details |
Topotecan hydrochloride | C23H24ClN3O5 | 119413-54-6 | Details |
Vorinostat | C14H20N2O3 | 149647-78-9 | Details |
Pictilisib | C23H27N7O3S2 | 957054-30-7 | Details |
Atorvastatin | C33H35FN2O5 | 134523-00-5 | Details |
PD 0325901 | C16H14F3IN2O4 | 391210-10-9 | Details |
ABT-888 | C13H16N4O | 912445-05-7 | Details |
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide | C23H20N6O | 726169-73-9 | Details |
GSK 525762A | C22H22ClN5O2 | 1260907-17-2 | Details |
Gemcitabine | C9H11F2N3O4 | 95058-81-4 | Details |
Dasatinib monohydrate | C22H28ClN7O3S | 863127-77-9 | Details |
Tozasertib | C23H28N8OS | 639089-54-6 | Details |
ABT 737 | C42H45ClN6O5S2 | 852808-04-9 | Details |
MK-0822 | C25H27F4N3O3S | 603139-19-1 | Details |
PIK-75 | C16H14BrN5O4S | 372196-67-3 | Details |
2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide | C19H14Cl2N2O3S | 879085-55-9 | Details |
PCI-27483 | C26H24N6O9S | 871266-63-6 | Details |
EPZ011969 | C35H51N5O4 | 1598383-40-4 | Details |
Etoposide phosphate | C29H33O16P | 117091-64-2 | Details |
Nilotinib | C28H22F3N7O | 641571-10-0 | Details |
Panobinostat | C21H23N3O2 | 404950-80-7 | Details |
Saracatinib | C27H32ClN5O5 | 379231-04-6 | Details |
AZD1152 | C26H30FN7O6P | 957881-03-7 | Details |
MLN-8237 | C27H20ClFN4O4 | 1028486-01-2 | Details |
CEP-37440 | C30H38ClN7O3 | 1391712-60-9 | Details |
Bosutinib | C26H29Cl2N5O3 | 380843-75-4 | Details |
Maraviroc | C29H41F2N5O | 376348-65-1 | Details |
MK 0524 | C21H19ClFNO4S | 571170-77-9 | Details |
CVT-6883 | C21H21F3N6O2 | 752222-83-6 | Details |
PLX-4720 | C17H14ClF2N3O3S | 918505-84-7 | Details |
MK-2206 2HCl | C25H22ClN5O | 1032350-13-2 | Details |
CYC-116 | C18H20N6OS | 1059105-22-4 | Details |
(S)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-triMethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate | C23H25ClN4O2S | 1268524-70-4 | Details |
Imatinib | C29H31N7O | 152459-95-5 | Details |
Axitinib | C22H18N4OS | 319460-85-0 | Details |
Gefitinib | C22H24ClFN4O3 | 184475-35-2 | Details |
Selumetinib | C17H15BrClFN4O3 | 606143-52-6 | Details |
Tivozanib | C22H19ClN4O5 | 475108-18-0 | Details |
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol | C18H14N6O2 | 677297-51-7 | Details |
AZD-8055 | C25H31N5O4 | 1009298-09-2 | Details |
LDK378 | C28H36ClN5O3S | 1032900-25-6 | Details |
Bortezomib | C19H25BN4O4 | 179324-69-7 | Details |
ZM 447439 | C29H31N5O4 | 331771-20-1 | Details |
Lapatinib | C29H26ClFN4O4S | 231277-92-2 | Details |
Pazopanib | C21H23N7O2S | 444731-52-6 | Details |
GSK1904529A | C44H47F2N9O5S | 1089283-49-7 | Details |
YM155 | C20H19BrN4O3 | 781661-94-7 | Details |
PP242 | C16H16N6O | 1092351-67-1 | Details |
Sorafenib | C21H16ClF3N4O3 | 284461-73-0 | Details |
7-(3,5-Dimethyl-4-isoxazolyl)-1,3-dihydro-8-methoxy-1-[(1R)-1-(2-pyridinyl)ethyl]-2H-imidazo[4,5-c]quinolin-2-one | C23H21N5O3 | 1300031-49-5 | Details |
Sunitinib | C22H27FN4O2 | 557795-19-4 | Details |
Product Total: Product Page: | ||||
1 2 3 |